Health and Healthcare
Health and Healthcare Articles
ArQule shares jumped early on Friday after the firm announced preliminary results from an early-stage study in patients with relapsed or refractory hematologic malignancies at the 2019 European...
Published:
Savara shares were absolutely crushed on Thursday after the company released its late-stage results for its treatment of autoimmune pulmonary alveolar proteinosis. Unfortunately, the study did not...
Published:
Whether you were in favor of or against the Affordable Care Act, it is likely of little surprise that the cost of health care has continued to rise. What also has risen handily is the number of...
Published:
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The May 31 short interest data have been compared with the previous report, and short interest in most...
Published:
Last Updated:
The May 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
One relatively small clinical-stage biopharmaceutical player called Global Blood Therapeutics may be about to change how sickle cell disease treatment goes.
Published:
Zynerba Pharma has just announced that the U.S. Patent and Trademark Office has issued a patent for the firm’s treatment of autism spectrum disorder with cannabidiol.
Published:
CymaBay Therapeutics shares were nearly halved early Tuesday after the company provided an update from its midstage study of seladelpar for the treatment of nonalcoholic steatohepatitis.
Published:
NovaBay shares absolutely exploded on Monday after the company announced that its eye care treatment would be readily available on Amazon.
Published:
A monoclonal antibody called teplizumab has been shown to delay the onset of type 1 diabetes for as long as two years. About 1.25 million Americans suffer from the disease, a form of diabetes in...
Published:
ReWalkshares took a step back on Monday after the firm announced that it would be pricing a registered direct offering for $5 million. This comes after the stock had a phenomenal week when the FDA...
Published:
Fentanyl-maker Insys Therapeutics has filed for bankruptcy protection while the company sells all its assets.
Published:
24/7 Wall St. has taken a look at Wedbush’s recent ASCO roundup, and we’ve picked out a few of the companies with the biggest upside potential going forward.
Published:
The problem of fake news has spread to health news, which can be critical to the well being of millions of American as they decide what drugs to take, what procedures to have, what doctors to see and...
Published:
Proton pump inhibitors (PPIs) — a widely prescribed group of medications that combat heartburn, GERD (gastroesophageal reflux disease), and ulcers — are the most widely prescribed class of drugs...
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.